Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1981-01-08
1982-04-27
Trousof, Natalie
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
260351, A61K 3112, C07C 5034
Patent
active
043271146
ABSTRACT:
Compounds of the formula ##STR1## wherein R.sub.1, R.sub.2, R.sub.3 and R.sub.4, which may be identical to or different from each other, are each hydrogen, halogen, branched alkyl of 3 to 12 carbon atoms or cycloalkyl of 3 to 12 carbon atoms, provided, however, that at least one of R.sub.1 to R.sub.4 is other than hydrogen; the compounds are useful as dermatologics for the treatment of psoriasis, dandruff, ichthyosis and hyperkeratotic skin conditions.
REFERENCES:
patent: 2929825 (1960-03-01), Stephens
patent: 3515731 (1970-06-01), Conover
patent: 3538126 (1970-11-01), Lange et al.
patent: 3947594 (1976-03-01), Randall
patent: 4007271 (1977-02-01), Robertson
Mustakallia, Acta Dermatovener, vol. 59, #85, p. 125, (1979).
Brickl Rolf
Eberhardt Hans
Boehringer Ingelheim GmbH
Reamer James H.
Trousof Natalie
LandOfFree
Substituted 1,8-dihydroxy-9-(10H)anthracenones does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted 1,8-dihydroxy-9-(10H)anthracenones, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted 1,8-dihydroxy-9-(10H)anthracenones will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2197686